+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 3
Age: 18Years - 75Years
MALE
ID06717711

Evaluating Low-Intensity Extracorporeal Shockwave Therapy Combined with PDE5 Inhibitors for Penile Rehabilitation After Robot-Assisted Surgery for Genitourinary Cancers

Led by Regina Elena Cancer Institute · Updated on 2026-08-14

158

Participants Needed

2

Research Sites

52 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the effectiveness of Low-intensity Extracorporeal Shock Wave Therapy Li-ESWT combined with PDE5 inhibitors PDE5i compared to PDE5i alone for treating erectile dysfunction ED after robot-assisted radical prostatectomy RARP in men with prostate cancer. This phase 3 randomized controlled trial aims to provide strong evidence on whether early penile rehabilitation using Li-ESWT plus PDE5i leads to faster and better recovery of erections as measured by the International Index of Erectile Function-5 IIEF-5. Participants are randomly assigned to two groups one receives Li-ESWT plus daily tadalafil 5 mg started shortly after catheter removal, and the other receives tadalafil alone. Li-ESWT is administered using a device delivering 12,000 shockwaves in a single session weekly for six weeks, targeting the erectile tissue with precise energy dosing. Both groups continue PDE5i treatment for one year, with assessments at 3, 6, and 12 months post-surgery. Participants will be monitored for erectile function using IIEF-5 and Erectile Hardness Score EHS, urinary continence, adverse effects, and health-related quality of life via questionnaires. PSA levels are measured 45 days after surgery to confirm eligibility. After one year, a two-week washout without PDE5i occurs to evaluate erectile function without medication. Data on safety, sexual recovery, and quality of life will be collected over the study period, which lasts up to one year after treatment.

CONDITIONS

Brief Title

Low-Intensity Extracorporeal Shockwave Therapy on Penile Rehabilitation After Robot-assisted Surgical Treatment of Genitourinary Cancers

Research Team

G

Giuseppe Simone

R

Riccardo Mastroianni

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here